Asia-Pacific Parkinson's Disease Treatment Market Report 2018

February 2018 | 118 pages | ID: A66555ACAC4EN
QYResearch

Abstracts

In this report, the Asia-Pacific Parkinson's Disease Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Parkinson's Disease Treatment for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Parkinson's Disease Treatment market competition by top manufacturers/players, with Parkinson's Disease Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teva (Israel)
• Novartis AG (Switzerland)
• GSK (UK)
• AbbVie (US)
• Merck (US)
• Boehringer Ingelheim (Germany)
• Impax Laboratories (US)
• Lundbeck (Denmark)
• UCB (Belgium)
• Valeant Pharmaceuticals (Canada)
• Acadia (US)
• Sun Pharma (India)
• Wockhardt (India)
• Dr. Reddy's (India)
• Intas (India)
• US WorldMeds (US)
• Zydus Cadila (India)
• Cipla (India)

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• Levodopa/carbidopa
• Dopamine Receptor Agonists
• MAO-Inhibitors
• COMT-inhibitors
• Anticholinergics
• Other Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacies
• Retailer Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Parkinson's Disease Treatment Market Report 2017

1 PARKINSON'S DISEASE TREATMENT OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Treatment
1.2 Classification of Parkinson's Disease Treatment by Product Category
  1.2.1 Asia-Pacific Parkinson's Disease Treatment Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Parkinson's Disease Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Levodopa/carbidopa
  1.2.4 Dopamine Receptor Agonists
  1.2.5 MAO-Inhibitors
  1.2.6 COMT-inhibitors
  1.2.7 Anticholinergics
  1.2.8 Other Drugs
1.3 Asia-Pacific Parkinson's Disease Treatment Market by Application/End Users
  1.3.1 Asia-Pacific Parkinson's Disease Treatment Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Retailer Pharmacies
  1.3.4 Online Pharmacies
1.4 Asia-Pacific Parkinson's Disease Treatment Market by Region
  1.4.1 Asia-Pacific Parkinson's Disease Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Parkinson's Disease Treatment (2012-2022)
  1.5.1 Asia-Pacific Parkinson's Disease Treatment Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Parkinson's Disease Treatment Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC PARKINSON'S DISEASE TREATMENT COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Parkinson's Disease Treatment Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Parkinson's Disease Treatment Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Parkinson's Disease Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Parkinson's Disease Treatment (Volume and Value) by Type
  2.2.1 Asia-Pacific Parkinson's Disease Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Parkinson's Disease Treatment Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Parkinson's Disease Treatment (Volume) by Application
2.4 Asia-Pacific Parkinson's Disease Treatment (Volume and Value) by Region
  2.4.1 Asia-Pacific Parkinson's Disease Treatment Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Parkinson's Disease Treatment Revenue and Market Share by Region (2012-2017)

3 CHINA PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE)

3.1 China Parkinson's Disease Treatment Sales and Value (2012-2017)
  3.1.1 China Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
  3.1.3 China Parkinson's Disease Treatment Sales Price Trend (2012-2017)
3.2 China Parkinson's Disease Treatment Sales Volume and Market Share by Type
3.3 China Parkinson's Disease Treatment Sales Volume and Market Share by Application

4 JAPAN PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Parkinson's Disease Treatment Sales and Value (2012-2017)
  4.1.1 Japan Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Parkinson's Disease Treatment Sales Price Trend (2012-2017)
4.2 Japan Parkinson's Disease Treatment Sales Volume and Market Share by Type
4.3 Japan Parkinson's Disease Treatment Sales Volume and Market Share by Application

5 SOUTH KOREA PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Parkinson's Disease Treatment Sales and Value (2012-2017)
  5.1.1 South Korea Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Parkinson's Disease Treatment Sales Price Trend (2012-2017)
5.2 South Korea Parkinson's Disease Treatment Sales Volume and Market Share by Type
5.3 South Korea Parkinson's Disease Treatment Sales Volume and Market Share by Application

6 TAIWAN PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Parkinson's Disease Treatment Sales and Value (2012-2017)
  6.1.1 Taiwan Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Parkinson's Disease Treatment Sales Price Trend (2012-2017)
6.2 Taiwan Parkinson's Disease Treatment Sales Volume and Market Share by Type
6.3 Taiwan Parkinson's Disease Treatment Sales Volume and Market Share by Application

7 INDIA PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE)

7.1 India Parkinson's Disease Treatment Sales and Value (2012-2017)
  7.1.1 India Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
  7.1.3 India Parkinson's Disease Treatment Sales Price Trend (2012-2017)
7.2 India Parkinson's Disease Treatment Sales Volume and Market Share by Type
7.3 India Parkinson's Disease Treatment Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Parkinson's Disease Treatment Sales and Value (2012-2017)
  8.1.1 Southeast Asia Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Parkinson's Disease Treatment Sales Price Trend (2012-2017)
8.2 Southeast Asia Parkinson's Disease Treatment Sales Volume and Market Share by Type
8.3 Southeast Asia Parkinson's Disease Treatment Sales Volume and Market Share by Application

9 AUSTRALIA PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Parkinson's Disease Treatment Sales and Value (2012-2017)
  9.1.1 Australia Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Parkinson's Disease Treatment Sales Price Trend (2012-2017)
9.2 Australia Parkinson's Disease Treatment Sales Volume and Market Share by Type
9.3 Australia Parkinson's Disease Treatment Sales Volume and Market Share by Application

10 ASIA-PACIFIC PARKINSON'S DISEASE TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Teva (Israel)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Teva (Israel) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Novartis AG (Switzerland)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Novartis AG (Switzerland) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 GSK (UK)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 GSK (UK) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 AbbVie (US)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 AbbVie (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Merck (US)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Merck (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Boehringer Ingelheim (Germany)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Impax Laboratories (US)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Impax Laboratories (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Lundbeck (Denmark)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Lundbeck (Denmark) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 UCB (Belgium)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 UCB (Belgium) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Valeant Pharmaceuticals (Canada)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Parkinson's Disease Treatment Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Acadia (US)
10.12 Sun Pharma (India)
10.13 Wockhardt (India)
10.14 Dr. Reddy's (India)
10.15 Intas (India)
10.16 US WorldMeds (US)
10.17 Zydus Cadila (India)
10.18 Cipla (India)

11 PARKINSON'S DISEASE TREATMENT MANUFACTURING COST ANALYSIS

11.1 Parkinson's Disease Treatment Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Parkinson's Disease Treatment

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Parkinson's Disease Treatment Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Parkinson's Disease Treatment Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PARKINSON'S DISEASE TREATMENT MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Parkinson's Disease Treatment Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Parkinson's Disease Treatment Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Parkinson's Disease Treatment Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Parkinson's Disease Treatment Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Parkinson's Disease Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Parkinson's Disease Treatment Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Parkinson's Disease Treatment Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Parkinson's Disease Treatment Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Parkinson's Disease Treatment Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Parkinson's Disease Treatment Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Parkinson's Disease Treatment Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Parkinson's Disease Treatment Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Parkinson's Disease Treatment
Figure Asia-Pacific Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Levodopa/carbidopa Product Picture
Figure Dopamine Receptor Agonists Product Picture
Figure MAO-Inhibitors Product Picture
Figure COMT-inhibitors Product Picture
Figure Anticholinergics Product Picture
Figure Other Drugs Product Picture
Figure Asia-Pacific Parkinson's Disease Treatment Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Parkinson's Disease Treatment by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retailer Pharmacies Examples
Table Key Downstream Customer in Retailer Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Asia-Pacific Parkinson's Disease Treatment Market Size (Million USD) by Region (2012-2022)
Figure China Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Parkinson's Disease Treatment Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Parkinson's Disease Treatment Sales Share by Players/Suppliers
Figure Asia-Pacific Parkinson's Disease Treatment Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Parkinson's Disease Treatment Revenue Share by Players
Figure 2017 Asia-Pacific Parkinson's Disease Treatment Revenue Share by Players
Table Asia-Pacific Parkinson's Disease Treatment Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Parkinson's Disease Treatment by Type (2012-2017)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Treatment by Type (2012-2017)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Parkinson's Disease Treatment by Region (2012-2017)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Market Share by Region in 2016
Table Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Treatment by Region (2012-2017)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Share by Region in 2016
Table Asia-Pacific Parkinson's Disease Treatment Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Parkinson's Disease Treatment Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Market Share by Application (2012-2017)
Figure China Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure China Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Parkinson's Disease Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table China Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2017)
Table China Parkinson's Disease Treatment Sales Volume Market Share by Type (2012-2017)
Figure China Parkinson's Disease Treatment Sales Volume Market Share by Type in 2016
Table China Parkinson's Disease Treatment Sales Volume (K Units) by Applications (2012-2017)
Table China Parkinson's Disease Treatment Sales Volume Market Share by Application (2012-2017)
Figure China Parkinson's Disease Treatment Sales Volume Market Share by Application in 2016
Figure Japan Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Parkinson's Disease Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2017)
Table Japan Parkinson's Disease Treatment Sales Volume Market Share by Type (2012-2017)
Figure Japan Parkinson's Disease Treatment Sales Volume Market Share by Type in 2016
Table Japan Parkinson's Disease Treatment Sales Volume (K Units) by Applications (2012-2017)
Table Japan Parkinson's Disease Treatment Sales Volume Market Share by Application (2012-2017)
Figure Japan Parkinson's Disease Treatment Sales Volume Market Share by Application in 2016
Figure South Korea Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Parkinson's Disease Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2017)
Table South Korea Parkinson's Disease Treatment Sales Volume Market Share by Type (2012-2017)
Figure South Korea Parkinson's Disease Treatment Sales Volume Market Share by Type in 2016
Table South Korea Parkinson's Disease Treatment Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Parkinson's Disease Treatment Sales Volume Market Share by Application (2012-2017)
Figure South Korea Parkinson's Disease Treatment Sales Volume Market Share by Application in 2016
Figure Taiwan Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Parkinson's Disease Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Parkinson's Disease Treatment Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Parkinson's Disease Treatment Sales Volume Market Share by Type in 2016
Table Taiwan Parkinson's Disease Treatment Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Parkinson's Disease Treatment Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Parkinson's Disease Treatment Sales Volume Market Share by Application in 2016
Figure India Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure India Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Parkinson's Disease Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table India Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2017)
Table India Parkinson's Disease Treatment Sales Volume Market Share by Type (2012-2017)
Figure India Parkinson's Disease Treatment Sales Volume Market Share by Type in 2016
Table India Parkinson's Disease Treatment Sales Volume (K Units) by Application (2012-2017)
Table India Parkinson's Disease Treatment Sales Volume Market Share by Application (2012-2017)
Figure India Parkinson's Disease Treatment Sales Volume Market Share by Application in 2016
Figure Southeast Asia Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Parkinson's Disease Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Parkinson's Disease Treatment Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Parkinson's Disease Treatment Sales Volume Market Share by Type in 2016
Table Southeast Asia Parkinson's Disease Treatment Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Parkinson's Disease Treatment Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Parkinson's Disease Treatment Sales Volume Market Share by Application in 2016
Figure Australia Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Parkinson's Disease Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2017)
Table Australia Parkinson's Disease Treatment Sales Volume Market Share by Type (2012-2017)
Figure Australia Parkinson's Disease Treatment Sales Volume Market Share by Type in 2016
Table Australia Parkinson's Disease Treatment Sales Volume (K Units) by Applications (2012-2017)
Table Australia Parkinson's Disease Treatment Sales Volume Market Share by Application (2012-2017)
Figure Australia Parkinson's Disease Treatment Sales Volume Market Share by Application in 2016
Table Teva (Israel) Parkinson's Disease Treatment Basic Information List
Table Teva (Israel) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis AG (Switzerland) Parkinson's Disease Treatment Basic Information List
Table Novartis AG (Switzerland) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table GSK (UK) Parkinson's Disease Treatment Basic Information List
Table GSK (UK) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table AbbVie (US) Parkinson's Disease Treatment Basic Information List
Table AbbVie (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck (US) Parkinson's Disease Treatment Basic Information List
Table Merck (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Basic Information List
Table Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table Impax Laboratories (US) Parkinson's Disease Treatment Basic Information List
Table Impax Laboratories (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table Lundbeck (Denmark) Parkinson's Disease Treatment Basic Information List
Table Lundbeck (Denmark) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table UCB (Belgium) Parkinson's Disease Treatment Basic Information List
Table UCB (Belgium) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Basic Information List
Table Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales Market Share in Asia-Pacific (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Revenue Market Share in Asia-Pacific (2012-2017)
Table Acadia (US) Parkinson's Disease Treatment Basic Information List
Table Sun Pharma (India) Parkinson's Disease Treatment Basic Information List
Table Wockhardt (India) Parkinson's Disease Treatment Basic Information List
Table Dr. Reddy's (India) Parkinson's Disease Treatment Basic Information List
Table Intas (India) Parkinson's Disease Treatment Basic Information List
Table US WorldMeds (US) Parkinson's Disease Treatment Basic Information List
Table Zydus Cadila (India) Parkinson's Disease Treatment Basic Information List
Table Cipla (India) Parkinson's Disease Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Treatment
Figure Manufacturing Process Analysis of Parkinson's Disease Treatment
Figure Parkinson's Disease Treatment Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Treatment Major Manufacturers in 2016
Table Major Buyers of Parkinson's Disease Treatment
Table Distributors/Traders List
Figure Asia-Pacific Parkinson's Disease Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Parkinson's Disease Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Share Forecast by Region in 2022
Figure China Parkinson's Disease Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Parkinson's Disease Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Parkinson's Disease Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Parkinson's Disease Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Parkinson's Disease Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Parkinson's Disease Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Parkinson's Disease Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Parkinson's Disease Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Parkinson's Disease Treatment Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Parkinson's Disease Treatment Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Parkinson's Disease Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources